THE SEROLOGIC MARKERS ASCA AND PANCA SHOW BETTER PREDICTABILITY THAN CRP, ESR AND CALPROTECTIN FOR ANTI- TNF TREATMENT AMONG PEDIATRIC IBD PATIENTS.

Christine Olbjørn  1     Milada Småstuen Cvancarova  2     Espen Thiis-Evensen  3     Britt Nakstad  4     Morten Harald Vatn     Gøri Perminow    
1 University of Oslo, Institute for Clinical Medicine, Campus Akershus University Hospital, Lørenskog, Norway
2 Oslo University Hospital, Ullevål, Gastroenterology, Oslo, Norway
3 University of Oslo, Gastroenterology, Rikshospitalet, Oslo, Norway
4 Akershus University Hospital and University of Oslo, Dep of Pediatrics and Adolescence and Ins

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing